Drug factory · FDA FEI 3003803288
Piramal Pharma Limited
Sy.Nos. 7-70, 70/1 and 70/2, Digwal Village, Kohir Mandal, Sangareddy, India
Problems found, fixed voluntarily at FDA's last inspection, Feb 13, 2026.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
6 drug inspections on record since 2012: 4 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Cinacalcet | Makes the active ingredient | Slate Run Pharmaceuticals, LLC. | 70436-007, 70436-008, 70436-009 |
| Isoflurane | Makes it, makes the active ingredient, tests it and packages it | Piramal Critical Care Inc. | 66794-017 |
| Metyrapone | Makes the active ingredient and tests it | Esteve Pharmaceuticals, S.a., HRA Pharma Rare Diseases | 68118-455, 76336-455 |
| Tafenoquine | Makes it | 60 Degrees Pharmaceuticals, INC. | 71475-258 |
| Tetrabenazine | Makes the active ingredient | Slate Run Pharmaceuticals, LLC. | 70436-101, 70436-102 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Feb 13, 2026 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Mar 31, 2023 | No problems found | Drug Quality Assurance | — |
| Mar 30, 2018 | No problems found | Drug Quality Assurance | — |
| Mar 25, 2016 | No problems found | Drug Quality Assurance | — |
| Jan 20, 2014 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Feb 2, 2012 | No problems found | Drug Quality Assurance | — |
Registered with FDA for: analysis; api manufacture; label; manufacture; pack; particle size reduction.